{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:50:40Z","timestamp":1761519040523},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T00:00:00Z","timestamp":1348790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00259-012-2244-3","type":"journal-article","created":{"date-parts":[[2012,9,28]],"date-time":"2012-09-28T03:45:25Z","timestamp":1348803925000},"page":"72-79","source":"Crossref","is-referenced-by-count":13,"title":["Semi-quantitative lymph node assessment of 18F-FDG PET\/CT in locally advanced breast cancer: correlation with biological prognostic factors"],"prefix":"10.1007","volume":"40","author":[{"given":"Ana Mar\u00eda","family":"Garc\u00eda Vicente","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Cruz Mora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Gonz\u00e1lez Ageitos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda del Mar","family":"Mu\u00f1oz S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Le\u00f3n Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Espinosa Auni\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Relea Calatayud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Mu\u00f1oz Madero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Chac\u00f3n L\u00f3pez-Mu\u00f1iz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Manuel","family":"Cordero Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Germ\u00e1n Andr\u00e9s","family":"Jim\u00e9nez Londo\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,28]]},"reference":[{"issue":"Suppl 1","key":"2244_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2007.2001","volume":"5","author":"DA Podoloff","year":"2007","unstructured":"Podoloff DA, Advani RH, Allred C, Benson AB, Brown E, Burstein HJ, et al. NCCN task force report: positron emission tomography (PET)\/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw 2007;5 Suppl 1:S1\u201322.","journal-title":"J Natl Compr Canc Netw"},{"key":"2244_CR2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejrad.2008.01.045","volume":"70","author":"AA Zytoon","year":"2009","unstructured":"Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET\/CT. Eur J Radiol 2009;70:530\u20138.","journal-title":"Eur J Radiol"},{"key":"2244_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bjs.6459","volume":"96","author":"A Gil-Rendo","year":"2009","unstructured":"Gil-Rendo A, Mart\u00ednez-Regueira F, Zornoza G, Garc\u00eda-Velloso MJ, Beorlequi C, Rodriguez-Spiteri N. Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer. Br J Surg 2009;96:166\u201370.","journal-title":"Br J Surg"},{"key":"2244_CR4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00259-002-0880-8","volume":"29","author":"A Buck","year":"2002","unstructured":"Buck A, Schirrmeister H, K\u00fchn T, Shen C, Kalker T, Kotzerke J, et al. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters. Eur J Nucl Med Mol Imaging 2002;29:1317\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2244_CR5","first-page":"9","volume":"42","author":"N Avril","year":"2001","unstructured":"Avril N, Menzel M, Dose J, Schelling M, Weber W, J\u00e4nicke F, et al. Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis. J Nucl Med 2001;42:9\u201316.","journal-title":"J Nucl Med"},{"key":"2244_CR6","first-page":"1440","volume":"47","author":"A Mavi","year":"2006","unstructured":"Mavi A, Urhan M, Yu JQ, Zhuang H, Houseni M, Cermik TF, et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity and correlates well with histologic subtypes. J Nucl Med 2006;47:1440\u20136.","journal-title":"J Nucl Med"},{"key":"2244_CR7","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/cncr.23226","volume":"112","author":"S Basu","year":"2008","unstructured":"Basu S, Chen W, Tchou J, Mavi A, Cermik T, Czerniecki B, et al. Comparison of triple-negative and estrogen receptor-positive\/progesterone receptor-positive\/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose\/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Cancer 2008;112:995\u20131000.","journal-title":"Cancer"},{"key":"2244_CR8","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2325\/jbcs.14.260","volume":"14","author":"W Shimoda","year":"2007","unstructured":"Shimoda W, Hayashi M, Murakami K, Oyama T, Sunagawa M. The relationship between FDG uptake in PET scans and biological behavior in breast cancer. Breast Cancer 2007;14:260\u20138.","journal-title":"Breast Cancer"},{"key":"2244_CR9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/RLU.0b013e31823926c9","volume":"37","author":"AM Garc\u00eda Vicente","year":"2012","unstructured":"Garc\u00eda Vicente AM, Castrej\u00f3n AS, Relea Calatayud F, Mu\u00f1oz AP, Le\u00f3n Mart\u00edn AA, L\u00f3pez-Mu\u00f1iz IC, et al. 18F-FDG retention index and biologic prognostic parameters in breast cancer. Clin Nucl Med 2012;37:460\u20136.","journal-title":"Clin Nucl Med"},{"key":"2244_CR10","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jjco\/hyp019","volume":"39","author":"BJ Chae","year":"2009","unstructured":"Chae BJ, Bae JS, Kang BJ, Kim SH, Jung SS, Song BJ. Positron emission tomography-computed tomography in the detection of axillary lymph node metastasis in patients with early stage breast cancer. Jpn J Clin Oncol 2009;39:284\u20139.","journal-title":"Jpn J Clin Oncol"},{"key":"2244_CR11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0212-6982(09)70706-2","volume":"28","author":"JR Garc\u00eda Garz\u00f3n","year":"2009","unstructured":"Garc\u00eda Garz\u00f3n JR, Rodr\u00edguez A, Cabrera A. Tomograf\u00eda por emisi\u00f3n de positrones de cuerpo completo (PET\/TAC) con 18F-fluorodesoxiglucosa. Rev Esp Med Nucl 2009;28:85\u20139.","journal-title":"Rev Esp Med Nucl"},{"key":"2244_CR12","unstructured":"American Joint Committee on Cancer. Cancer staging manual. 7th ed. http:\/\/www.cancerstaging.org\/staging\/index.html ."},{"key":"2244_CR13","first-page":"4","volume":"39","author":"F Crippa","year":"1998","unstructured":"Crippa F, Agresti R, Seregni E, Greco M, Pascali C, Bogni A, et al. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4\u20138.","journal-title":"J Nucl Med"},{"key":"2244_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00432-003-0536-5","volume":"130","author":"T Inoue","year":"2004","unstructured":"Inoue T, Yutani K, Taguchi T, Tamaki Y, Shiba E, Noguchi S. Preoperative evaluation of prognosis in breast cancer patients by [(18)F]2-deoxy-2-fluoro-D-glucose-positron emission tomography. J Cancer Res Clin Oncol 2004;130:273\u20138.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2244_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12282-008-0065-9","volume":"16","author":"T Uematsu","year":"2009","unstructured":"Uematsu T, Kasami M, Yuen S. Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy. Breast Cancer 2009;16:97\u2013104.","journal-title":"Breast Cancer"},{"key":"2244_CR16","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1093\/jjco\/hyn019","volume":"38","author":"S Ueda","year":"2008","unstructured":"Ueda S, Tsuda H, Asakawa H, Shigekawa T, Fukatsu K, Kondo N, et al. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in primary breast cancer. Jpn J Clin Oncol 2008;38:250\u20138.","journal-title":"Jpn J Clin Oncol"},{"key":"2244_CR17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1471-2407-8-165","volume":"8","author":"S Ueda","year":"2008","unstructured":"Ueda S, Tsuda H, Asakawa H, Omata J, Fukatsu K, Kondo N, et al. Utility of 18F-fluoro-deoxyglucose emission tomography\/computed tomography fusion imaging (18F-FDG PET\/CT) in combination with ultrasonography for axillary staging in primary breast cancer. BMC Cancer 2008;8:165.","journal-title":"BMC Cancer"},{"key":"2244_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jjco\/hyn120","volume":"39","author":"T Taira","year":"2009","unstructured":"Taira T, Ohsumi S, Takabatake D, Hara F, Takashima S, Aogi K, et al. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography\/computed tomography fusion imaging. Jpn J Clin Oncol 2009;39:16\u201321.","journal-title":"Jpn J Clin Oncol"},{"key":"2244_CR19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.acra.2012.01.001","volume":"19","author":"S Carkaci","year":"2012","unstructured":"Carkaci S, Adrada BE, Rohren E, Wei W, Quraishi MA, Mawlawi O, et al. Semiquantitative analysis of maximum standardized uptake values of regional lymph nodes in inflammatory breast cancer: is there a reliable threshold for differentiating benign from malignant? Acad Radiol 2012;19:535\u201341.","journal-title":"Acad Radiol"},{"key":"2244_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12149-012-0579-2","volume":"26","author":"Y Sanli","year":"2012","unstructured":"Sanli Y, Kuyumcu S, Ozkan ZG, I\u015fik G, Karanlik H, Guzelbey B, et al. Increased FDG uptake in breast cancer is associated with prognostic factors. Ann Nucl Med 2012;26:345\u201350.","journal-title":"Ann Nucl Med"},{"key":"2244_CR21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-010-0771-9","volume":"123","author":"R Peare","year":"2010","unstructured":"Peare R, Staff RT, Heys SD. The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat 2010;123:281\u201390.","journal-title":"Breast Cancer Res Treat"},{"key":"2244_CR22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene. Science 1987;235:177\u201382.","journal-title":"Science"},{"key":"2244_CR23","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.suronc.2008.11.001","volume":"19","author":"N Patani","year":"2010","unstructured":"Patani N, Mokbel K. Herceptin and breast cancer: an overview for surgeons. Surg Oncol 2010;19:e11\u201321.","journal-title":"Surg Oncol"},{"key":"2244_CR24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jcp.2004.022772","volume":"58","author":"HJ Huang","year":"2005","unstructured":"Huang HJ, Neven P, Drijkoningen M, Paridaens R, Wildiers H, Van Limbergen E, et al. Association between tumour characteristics and HER-2\/neu by immunohistochemistry in 1362 women with primary operable breast cancer. J Clin Pathol 2005;58:611\u20136.","journal-title":"J Clin Pathol"},{"key":"2244_CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2184.2000.00165.x","volume":"33","author":"F Barzanti","year":"2000","unstructured":"Barzanti F, Dal Susino M, Volpi A, Amadori D, Riccobon A, Scarpi E, et al. Comparison between different cell kinetic variables in human breast cancer. Cell Prolif 2000;33:75\u201389.","journal-title":"Cell Prolif"},{"key":"2244_CR26","doi-asserted-by":"crossref","first-page":"R6","DOI":"10.1186\/bcr1639","volume":"9","author":"LK Dunnwald","year":"2007","unstructured":"Dunnwald LK, Rossing MA, Li CI. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 2007;9:R6.","journal-title":"Breast Cancer Res"},{"key":"2244_CR27","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938\u201348.","journal-title":"N Engl J Med"},{"key":"2244_CR28","unstructured":"Garc\u00eda Vicente AM, Soriano Castrej\u00f3n A, Relea Calatayud F, Mu\u00f1oz Madero V, Molina Garrido MJ, Le\u00f3n Mart\u00edn, et al. 18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer. Rev Esp Med Nucl Imagen Mol [Epub ahead of print]."}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-012-2244-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-012-2244-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-012-2244-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T07:39:42Z","timestamp":1594712382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-012-2244-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2244"],"URL":"https:\/\/doi.org\/10.1007\/s00259-012-2244-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,28]]}}}